Market Research Logo

Advaxis, Inc. - Product Pipeline Review - 2016

Advaxis, Inc. Snapshot
Advaxis, Inc. Overview
Key Information
Key Facts
Advaxis, Inc. - Research and Development Overview
Key Therapeutic Areas
Advaxis, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Advaxis, Inc. - Pipeline Products Glance
Advaxis, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Advaxis, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Advaxis, Inc. - Drug Profiles
axalimogene filolisbac
Product Description
Mechanism of Action
R&D Progress
ADXS-HER2
Product Description
Mechanism of Action
R&D Progress
ADXS-PSA
Product Description
Mechanism of Action
R&D Progress
Adxs-LmddA159
Product Description
Mechanism of Action
R&D Progress
ADXS-NEO
Product Description
Mechanism of Action
R&D Progress
ADXS-TNBC
Product Description
Mechanism of Action
R&D Progress
Lm-LLO-CA9
Product Description
Mechanism of Action
R&D Progress
Lm-LLO-CD105A
Product Description
Mechanism of Action
R&D Progress
Lm-LLO-Flk1
Product Description
Mechanism of Action
R&D Progress
Lm-LLO-HMWMAAC
Product Description
Mechanism of Action
R&D Progress
Lm-LLO-ISG15
Product Description
Mechanism of Action
R&D Progress
Lovaxin S
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target CEA for Ovarian Cancer
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target FAP for Breast and Colorectal Cancer
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target HER2 and CA9 for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target Her2 and HMWMAA for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target IL-13R Alpha2 for Solid Tumor
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target PSA and HMWMAA for Prostate Cancer
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target PSCA for Prostate Cancer
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target WT1 for Oncology
Product Description
Mechanism of Action
R&D Progress
Advaxis, Inc. - Pipeline Analysis
Advaxis, Inc. - Pipeline Products by Target
Advaxis, Inc. - Pipeline Products by Route of Administration
Advaxis, Inc. - Pipeline Products by Molecule Type
Advaxis, Inc. - Recent Pipeline Updates
Advaxis, Inc. - Dormant Projects
Advaxis, Inc. - Company Statement
Advaxis, Inc. - Company Statement
Advaxis, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Advaxis, Inc., Key Information
Advaxis, Inc., Key Facts
Advaxis, Inc. - Pipeline by Indication, 2016
Advaxis, Inc. - Pipeline by Stage of Development, 2016
Advaxis, Inc. - Monotherapy Products in Pipeline, 2016
Advaxis, Inc. - Phase II, 2016
Advaxis, Inc. - Phase I, 2016
Advaxis, Inc. - Preclinical, 2016
Advaxis, Inc. - Pipeline by Target, 2016
Advaxis, Inc. - Pipeline by Route of Administration, 2016
Advaxis, Inc. - Pipeline by Molecule Type, 2016
Advaxis, Inc. - Recent Pipeline Updates, 2016
Advaxis, Inc. - Dormant Developmental Projects,2016
List of Figures
Advaxis, Inc. - Pipeline by Top 10 Indication, 2016
Advaxis, Inc. - Pipeline by Stage of Development, 2016
Advaxis, Inc. - Monotherapy Products in Pipeline, 2016
Advaxis, Inc. - Pipeline by Top 10 Target, 2016
Advaxis, Inc. - Pipeline by Route of Administration, 2016
Advaxis, Inc. - Pipeline by Molecule Type, 2016

Advaxis, Inc. - Product Pipeline Review - 2016

Summary


Global Markets Direct’s, ‘Advaxis, Inc. - Product Pipeline Review - 2016’, provides an overview of the Advaxis, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Advaxis, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Advaxis, Inc.
  • The report provides overview of Advaxis, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Advaxis, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Advaxis, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Advaxis, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Advaxis, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Advaxis, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;